ProfileGDS4718 / 212312_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 92% 92% 86% 94% 93% 95% 95% 92% 94% 92% 93% 94% 89% 95% 90% 90% 91% 92% 89% 89% 92% 94% 91% 91% 92% 95% 93% 95% 89% 96% 91% 93% 92% 92% 95% 96% 92% 92% 92% 87% 91% 96% 95% 92% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.5696492
GSM549102patient 115, normal, homogenized [OPG study]9.6261892
GSM549104patient 119, normal, homogenized [OPG study]8.6245786
GSM549108patient 138, normal, homogenized [OPG study]9.8520694
GSM549119patient 077, normal, homogenized [OPG study]9.8850593
GSM549133patient 032, cancer, homogenized [OPG study]10.274895
GSM549139patient 042, cancer, homogenized [OPG study]10.188595
GSM549099patient 107, normal, homogenized [OPG study]9.4892992
GSM549109patient 139, normal, homogenized [OPG study]9.9409294
GSM549110patient 046, normal, homogenized [OPG study]9.6391792
GSM549114patient 063, normal, homogenized [OPG study]9.9213993
GSM549122patient 082, normal, homogenized [OPG study]9.9966394
GSM549134patient 033, cancer, homogenized [OPG study]9.0691289
GSM549136patient 036, cancer, homogenized [OPG study]10.220495
GSM549140patient 044, cancer, homogenized [OPG study]9.2655190
GSM549111patient 047, normal, homogenized [OPG study]9.2348590
GSM549113patient 057, normal, homogenized [OPG study]9.6545791
GSM549132patient 031, cancer, homogenized [OPG study]9.5056692
GSM549137patient 038, cancer, homogenized [OPG study]9.0181589
GSM549142patient 047, cancer, homogenized [OPG study]8.6353389
GSM549100patient 110, normal, homogenized [OPG study]9.5244792
GSM549107patient 135, normal, homogenized [OPG study]9.9845894
GSM549115patient 068, normal, homogenized [OPG study]9.6557591
GSM549116patient 072, normal, homogenized [OPG study]9.5209891
GSM549120patient 078, normal, homogenized [OPG study]9.6127392
GSM549131patient 030, cancer, homogenized [OPG study]10.279595
GSM549118patient 074, normal, homogenized [OPG study]9.8717493
GSM549129patient 027, cancer, homogenized [OPG study]10.038995
GSM549123patient 088, normal, homogenized [OPG study]9.0834889
GSM549124patient 006, cancer, homogenized [OPG study]10.469296
GSM549126patient 015, cancer, homogenized [OPG study]9.3279291
GSM549128patient 025, cancer, homogenized [OPG study]9.684693
GSM549103patient 117, normal, homogenized [OPG study]9.5336492
GSM549117patient 073, normal, homogenized [OPG study]9.6435592
GSM549138patient 041, cancer, homogenized [OPG study]10.126195
GSM549141patient 045, cancer, homogenized [OPG study]10.673796
GSM549130patient 028, cancer, homogenized [OPG study]9.5188592
GSM549101patient 111, normal, homogenized [OPG study]9.4916992
GSM549105patient 128, normal, homogenized [OPG study]9.574192
GSM549106patient 134, normal, homogenized [OPG study]8.8901687
GSM549112patient 048, normal, homogenized [OPG study]9.4404691
GSM549125patient 011, cancer, homogenized [OPG study]10.532996
GSM549127patient 024, cancer, homogenized [OPG study]10.159195
GSM549135patient 035, cancer, homogenized [OPG study]9.5480792